Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2003
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003US20030225058 Modulation of the activity of serotonin receptors (5-HT) to treat diseases such as anxiety, depression or obesity
12/04/2003US20030225057 3-Benzoazepine derivatives
12/04/2003US20030225056 Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/04/2003US20030225036 E.g., 2-(5-Amino-1H-pyrrolo(2,3-c)pyridin-2-yl)-4,6-dichlorophenol and 2-(5-Amino-3-benzyl-1H-pyrrolo(2,3-c)pyridin-2-yl)-4,6-dichlorophenol; utility as anti-coagulants
12/04/2003CA2487017A1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/03/2003EP1366760A1 Tablets quickly disintegrated in oral cavity
12/03/2003EP1366051A2 Solid forms of tin ethyl etiopurpurin and processes for producing such forms
12/03/2003EP1366050A2 Condensed pyrazindione derivatives as pde inhibitors
12/03/2003EP1365763A1 Farnesyl protein transferase inhibitor combinations with antiestrogen agents
12/03/2003EP1257555B1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/03/2003EP1194375B1 Synthetic porous crystalline mcm-68, its synthesis and use
12/03/2003EP1117659B1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
12/03/2003EP1097935B1 X-ray intercepting metal complexes of chlorin derivatives
12/03/2003EP1030648B1 DYEING COMPOSITION CONTAINING A PYRAZOLO- 1,5-a]-PYRIMIDINE AS OXIDATION BASE AND A PYRIDINE COUPLING AGENT, AND DYEING METHOD
12/03/2003EP1030647B1 DYEING COMPOSITION CONTAINING A PYRAZOLO- 1,5-a]-PYRIMIDINE AS OXIDATION BASE AND A NAPHTHALENE COUPLING AGENT, AND DYEING METHOD
12/03/2003EP0973395B1 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
12/03/2003EP0693072B1 Method for the synthesis of 4- and/or 5-(di)substituted 2-aminoimidazoles from 2-aminoimidazoles and aldehydes
12/03/2003CN1460104A Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/03/2003CN1129578C Tetrahydrobenzindole derivs
12/02/2003US6657884 High density non-volatile memory device
12/02/2003US6657066 Forming a 1H-pyrazolo (1,5-b)-(1,2,4)-triazole compound by cyclization of pyrazoloamidine compound comprising reacting amidine with oxidizing agent in presence of halogen
12/02/2003US6657064 For use as analgesics
12/02/2003US6657063 Combinations of β3 agonists and growth hormone secretagogues
12/02/2003US6657058 Metal free texaphyrin synthesis
12/02/2003US6656964 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/02/2003US6656945 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-one cGMP-PDE inhibitors for the treatment of erectile dysfunction
12/02/2003US6656940 Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656935 Aromatic nitrogen-containing 6-membered cyclic compounds
12/02/2003US6656930 Aralkyl diazabicycloalkane derivatives for CNS disorders
12/02/2003US6656450 Macrocyclic magnetic resonance imaging contrast agents
11/2003
11/27/2003WO2003097862A1 Method of searching substane having antidiabetic activity
11/27/2003WO2003097646A1 Acyl bicyclix derivatives of pyrrol
11/27/2003WO2003097645A1 5-ethylimidarotriazones
11/27/2003WO2003097635A1 Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-[ring fused indol-5-yl(amine-derived)] compounds and analogues thereof, and to products obtained therefrom
11/27/2003WO2003097608A2 Opioid and opioid-like compounds and uses thereof
11/27/2003WO2003097571A1 Process for hydrogenating unactivated imines using ruthenium complexes as catalysts
11/27/2003WO2003097356A1 Camptothecin derivatives and polymeric conjugates thereof
11/27/2003WO2003097062A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003WO2003097061A1 External preparation for allergic diseases
11/27/2003WO2003096980A2 Bicyclic modulators of androgen receptor function
11/27/2003WO2003096782A2 Process for preparing maytansinol
11/27/2003WO2003065983A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/27/2003WO2003056899A3 Nitric oxide donors for treatment of disease and injury
11/27/2003WO2003053354A3 Fused cyclic modulators of nuclear hormone receptor function
11/27/2003WO2003037338A3 Modulators of the cholesterol biosynthetic pathway
11/27/2003WO2003020222A3 PYRROLO[2,3-d]PYRIMIDINES FOR INHIBITING RNA-DEPENDENT RNA VIRAL POLYMERASE
11/27/2003WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor
11/27/2003US20030220498 Use of toxicologically benign iron salts or iron complexes as the catalysts, and commercially attractive aryl chlorides as well as various aryl sulfonates and aryl phosphonates can be used as starting materials
11/27/2003US20030220423 A polymerization catalyst for free radical polymerization of ethylenically unsaturated monomers
11/27/2003US20030220393 Substituted phthalides, a process for their preparations and pharmaceutical compositions containing them
11/27/2003US20030220388 Indoline derivatives
11/27/2003US20030220358 A1 adenosine receptro antagonists
11/27/2003US20030220353 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220342 Use of such compounds as corticotropin releasing factor receptor antagonists in the treatment of various neurological disorders
11/27/2003US20030220333 Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
11/27/2003US20030220330 Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
11/27/2003US20030220328 For treatment of cell adhesion-mediated disease and central nervous system disorders; for antagonizing effects of substance P
11/27/2003US20030220324 Substituted piperazines and methods of use
11/27/2003US20030220322 Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and use
11/27/2003US20030220321 Such as 10-(2-ethoxyphenyl)-1,2,3,4,5,6-hexahydroazepino(4,5-b)indole; for treatment of anxiety, depression, schizophrenia, epilepsy, migraine, Alzheimers disease, sleep disorders, obesity, stress related diseases, and/or drug withdrawal
11/27/2003US20030220318 New phenylalanine derivatives
11/27/2003US20030220316 Such as N-(1-(1-methylethyl)piperidin-4-yl)-N-((4-methyl phenyl)methyl)-4-methoxyphenylacetamide for stimulation of serotonin receptors
11/27/2003US20030220268 New phenylalanine derivatives
11/27/2003US20030219898 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
11/27/2003CA2486157A1 Opioid and opioid-like compounds and uses thereof
11/27/2003CA2485933A1 5-ethylimidarotriazones
11/27/2003CA2485006A1 Camptothecin derivatives and polymeric conjugates thereof
11/27/2003CA2484631A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003CA2483190A1 External preparation for allergic diseases
11/26/2003EP1364953A1 Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine a3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating glaucoma and method of lowering ocular tension
11/26/2003EP1364952A1 Bicyclic nitrogenous fused-ring compound
11/26/2003EP1364212A2 Three hybrid assay system
11/26/2003EP1363993A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF I$g(k)B KINASE (IKK)
11/26/2003EP1363916A2 Emissive multichromophoric systems
11/26/2003EP1363915A1 Substituted calix (4) pyrroles and process for the synthesis of calix (4) pyrroles over molecular sieve catalysts
11/26/2003EP1363914A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents
11/26/2003EP1363913A2 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
11/26/2003EP1363912A1 Novel substituted imidazotriazinones
11/26/2003EP1363911A1 Synthesis of temozolomide and analogs
11/26/2003EP1363910A2 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
11/26/2003EP1363899A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363702A1 Methods of inhibiting kinases
11/26/2003EP1363644A2 Modulation of gsk-3beta activity and its different uses
11/26/2003EP1363639A1 PYRROLO 2,3-d]PYRIMIDINE AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363605A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
11/26/2003EP1363581A2 Pyrrolo(2,3-d)pyrimidine nucleoside analogs
11/26/2003EP1054888B1 Fungicidal 7-alkyl-triazolopyrimidines
11/26/2003EP1017700B1 Macrocyclic porphyrazine-type compounds, metal derivatives thereof and process for their preparation
11/26/2003EP0760375B1 Antitumor indolopyprolocarbazole derivative
11/26/2003EP0757038B1 Benzamide compound and medicinal use thereof
11/26/2003EP0708777B1 Abeo-ergoline derivatives as 5ht1a ligands
11/26/2003EP0673937B1 Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives
11/26/2003CN1459127A Light harvesting arrays
11/26/2003CN1458979A Modulating multiple lineage kinase proteins
1 ... 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 ... 573